3 news items
Alimera Sciences Reports First Quarter 2024 Results
ALIM
14 May 24
Study, a prospective, open-label clinical study evaluating the safety and efficacy of YUTIQ (fluocinolone acetonide intravitreal implant 0.18mg
Alimera Announces Scientific Data Highlighting YUTIQ To Be Presented At Upcoming Association For Research In Vision And Ophthalmology And Retina World Congress Conferences
ALIM
7 May 24
: 24-Month Safety Outcomes From a Real-World Registry Study of Patients with Chronic Non-infectious Uveitis Affecting the Posterior Segment Treated
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results
ALIM
7 Mar 24
the safety and efficacy of YUTIQ for the treatment of macular edema associated with chronic, non-infectious uveitis affecting the posterior segment of the eye
- Prev
- 1
- Next